BioMarin Pharmaceutical Earnings
NASDAQ: BMRNHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Next earnings date
Mon, Oct 26, 2026
Fiscal period
Sep/2026
EPS estimate
$1.13
BioMarin Pharmaceutical earnings summary
BioMarin Pharmaceutical is scheduled to report Sep/2026 earnings on Oct 26, 2026, with analysts expecting EPS of $1.13. In its most recent report on Aug 6, 2026 (Q2 2026), BMRN posted EPS of $0.23. Revenue for the quarter was $989.7 million.
Quarterly EPS is down 81.3% from the same quarter a year earlier. Across the last 16 reports, BMRN shares moved an average of 3.1% (in either direction) in the first trading session after results, rising 9 times and falling 7 times.
Summary generated from market data by MetaCap's automated system. Methodology
BMRN earnings history
| Report date | EPS est. | EPS actual | Surprise | Price reaction |
|---|---|---|---|---|
| Aug 6, 2026 | — | $0.23 | — | +5.6% |
| May 5, 2026 | — | $0.54 | — | -4.2% |
| Feb 26, 2026 | — | $-0.22 | — | -1.0% |
| Oct 28, 2025 | — | $-0.16 | — | -3.9% |
| Aug 5, 2025 | — | $1.23 | — | +0.4% |
| May 2, 2025 | — | $0.95 | — | -5.1% |
| Feb 24, 2025 | — | $0.65 | — | +1.5% |
| Oct 31, 2024 | — | $0.55 | — | +0.7% |
| Aug 5, 2024 | — | $0.55 | — | +1.0% |
| Apr 26, 2024 | — | $0.46 | — | +1.9% |
| Feb 26, 2024 | — | $0.10 | — | -1.4% |
| Nov 2, 2023 | — | $0.21 | — | +5.5% |
| Aug 2, 2023 | — | $0.29 | — | +1.0% |
| Apr 28, 2023 | — | $0.27 | — | +0.6% |
| Feb 27, 2023 | — | $0.01 | — | -10.6% |
| Oct 28, 2022 | — | $-0.04 | — | -4.9% |
Surprise compares reported EPS with the consensus estimate. Price reaction is the close-to-close move in the first session after the report. Learn about the earnings surprise.